The AHSNs have a dual regional and national focus. We deliver local work programmes based on the needs of our regional systems and collectively drive initiatives that tackle national priorities and are expected to have a universal impact at scale.
This report focuses on our national work and impact. To learn more about the activity of individual AHSNs in different parts of the country, visit the individual AHSN websites.
In 2021-22, our national innovation spread programmes included:
Lipid Management and Familial Hypercholesterolaemia – Working with trusts and primary care to improve the management of cholesterol, increase the detection of those with Familial Hypercholesterolaemia and optimise the use of all medicines for patients on the cholesterol management pathway.
Early Intervention Eating Disorders – Supporting mental health teams to speed up diagnosis and treatment of eating disorders in people aged 16-25 with an evidence-based specialist care package.
Focus ADHD – Working with mental health trusts and community paediatric services to improve the assessment process for ADHD by implementing an objective assessment tool.
You can see the impact and local examples of the roll-out of these programmes on the following pages. This year, we also developed several new adoption and spread programmes for 2022 onwards. These include:
Blood pressure optimisation – Working with Primary Care Networks (PCNs) to roll out a framework that supports and optimises proactive care for people with hypertension.
Transforming wound care – Using evidenced-based care to reduce variation in chronic lower limb wound care to improve experience and outcomes for patients.
Polypharmacy – Supporting local systems and primary care to identify patients at potential risk of harm and promoting shared decision making with patients.
Read our impacts stories for this area below or visit the AHSN Network Impact Report 2021-22 main page.